Anavex Life Sciences
AVXL
#7351
Rank
A$0.59 B
Marketcap
A$6.41
Share price
-3.40%
Change (1 day)
-55.96%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2025 (TTM): -A$73.29 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$72.58 Million a decrease over its 2023 earnings that were of -A$63.24 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$73.29 Million0.98%
2024 -A$72.58 Million14.77%
2023 -A$63.24 Million-17.49%
2022 -A$76.64 Million22.96%
2021 -A$62.33 Million35.36%
2020 -A$46.05 Million12.65%
2019 -A$40.88 Million29.09%
2018 -A$31.67 Million36.33%
2017 -A$23.23 Million17.11%
2016 -A$19.84 Million20.91%
2015 -A$16.41 Million-6.29%
2014 -A$17.51 Million337.28%
2013 -A$4.01 Million
2008 -A$7.41 Million106.01%
2007 -A$3.6 Million8848.98%
2006 -A$0.05 Million-79.99%
2005 -A$0.21 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
A$94.02 M-242.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
A$92.3 M-240.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-A$6.76 Million-89.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-A$9.32 Million-85.86%๐Ÿ‡บ๐Ÿ‡ธ USA